Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
CodeAllP: Open-market purchaseS: Open-market saleA: Grant or awardM: Option exerciseF: Tax withholdingG: GiftD: Disposition to issuerC: ConversionX: In-the-money exerciseJ: Other
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | INGENITO GARY Chief Med. & Reg. Officer | MOption exercise Restricted Stock Unitsderivative | -9,000 | $0.00 | $0 | 1,025,282 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 2,746 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Harper Molly director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 131,274 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Common Stock, par value $0.001 per share | +6,667 | - | - | 183,191 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Elsbernd Brian Chief Compliance/Legal Officer | FTax withholding Common Stock, par value $0.001 per share | -1,941 | - | - | 181,250 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Elsbernd Brian Chief Compliance/Legal Officer | MOption exercise Restricted Stock Unitsderivative | -6,667 | $0.00 | $0 | 1,081,276 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | DENKHAUS DONALD A director | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 441,079 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | DENKHAUS DONALD A director | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 212,274 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey Chief Commercial Officer | MOption exercise Common stock, par value $0.001 per share | +8,667 | - | - | 26,720 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey Chief Commercial Officer | FTax withholding Common stock, par value $0.001 per share | -3,839 | - | - | 22,881 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Del Carmen Jeffrey Chief Commercial Officer | MOption exercise Restricted Stock Unitsderivative | -8,667 | $0.00 | $0 | 941,675 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Daly Richard J President and CEO | MOption exercise Common Stock, par value $0.001 per share | +1,333 | - | - | 236,157 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Daly Richard J President and CEO | FTax withholding Common Stock, par value $0.001 per share | -324 | - | - | 235,833 | Dec 31, 2024 |
| Dec 27, 2024 | CPRX CATALYST PHARMACEUTICALS, INC. | Daly Richard J President and CEO | MOption exercise Restricted Stock Unitsderivative | -1,333 | $0.00 | $0 | 2,280,858 | Dec 31, 2024 |
| Dec 30, 2024 | DAY Dayforce, Inc. | HAGERTY THOMAS M director | GGift Common Stock | -14,000 | - | - | 76,745 | Dec 31, 2024 |
| Dec 31, 2024 | CSGS CSG SYSTEMS INTERNATIONAL INC | Shepherd Brian A. President & CEO | DDisposition to issuer Common Stock | -42,135 | $0.00 | $0 | 540,194 | Dec 31, 2024 |
| Dec 27, 2024 | VFC V F CORP | CHO ALEX director | AGrant or award Phantom Stockderivative | +1,148 | $21.77 | $25k | 13,205 | Dec 31, 2024 |
| Dec 27, 2024 | VFC V F CORP | Carucci Richard director | AGrant or award Phantom Stock-dderivative | +3,445 | $21.77 | $75k | 68,316 | Dec 31, 2024 |
| Dec 30, 2024 | OVBC OHIO VALLEY BANC CORP | EASTMAN BRENT R director | JOther Common Shares | +2,754 | $24.23 | $67k | 79,666 | Dec 31, 2024 |
| Dec 30, 2024 | OVBC OHIO VALLEY BANC CORP | CANADY KIMBERLY A director | JOther Common Sharesindirect: Spouse C/F Son (REC) | +0 | $24.23 | $4 | 4 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Marissa Solis Michel director | DDisposition to issuer Common Stock, par value $0.01 per share | -87,658 | $4.70 | $412k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | GERKE THOMAS A director | DDisposition to issuer Common Stock, par value $0.01 per share | -173,679 | $4.70 | $816k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Rahe Maribeth S director | DDisposition to issuer Common Stock, par value $0.01 per share | -203,319 | $4.70 | $956k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Udell C Robert JR President & CEO | DDisposition to issuer Common Stock, par value $0.01 per share | -1,539,593 | $4.70 | $7.2M | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Graffam Fred Chief Financial Officer | DDisposition to issuer Common Stock, par value $0.01 per share | -304,271 | $4.70 | $1.4M | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | CURREY ROBERT J director | DDisposition to issuer Common Stock, par value $0.01 per share | -223,378 | $4.70 | $1.0M | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | CURREY ROBERT J director | DDisposition to issuer Common Stock, par value $0.01 per shareindirect: Robert J. Currey, Revocable Trust | -71,793 | $4.70 | $337k | 0 | Dec 31, 2024 |
| Dec 27, 2024 | CNSL Consolidated Communications Holdings, Inc. | Fuller David G director | DDisposition to issuer Common Stock, par value $0.01 per share | -109,746 | $4.70 | $516k | 0 | Dec 31, 2024 |
| Dec 31, 2024 | RAIN Rain Enhancement Technologies Holdco, Inc. | DACIER PAUL T owner | POpen-market purchase Class A Common Stockindirect: By Rainwater LLC | +8,782 | $11.39 | $100k | 1,848,104 | Dec 31, 2024 |
| Dec 31, 2024 | RAIN Rain Enhancement Technologies Holdco, Inc. | DICKERSON LYMAN B director | AGrant or award Class A Common Stock | +17,564 | $11.39 | $200k | 17,564 | Dec 31, 2024 |
| Dec 30, 2024 | GTE GRAN TIERRA ENERGY INC. | Abraham Phillip D VP, Legal and Business Dev. | AGrant or award Common Stock | +331 | $7.02 | $2,324 | 27,031 | Dec 31, 2024 |
| Dec 30, 2024 | BHR Braemar Hotels & Resorts Inc. | Musser Rebecca director | AGrant or award Common Stock | +5,561 | $0.00 | $0 | 5,561 | Dec 31, 2024 |
| Dec 30, 2024 | OKLO Oklo Inc. | Cochran Caroline Co-Founder, COO | GGift Class A Common Stock | -35,000 | $0.00 | $0 | 12,508,085 | Dec 31, 2024 |
| Dec 30, 2024 | OKLO Oklo Inc. | Cochran Caroline Co-Founder, COO | GGift Class A Common Stockindirect: By Jacob DeWitte | -35,000 | $0.00 | $0 | 13,068,926 | Dec 31, 2024 |
| Dec 30, 2024 | OKLO Oklo Inc. | DeWitte Jacob Co-Founder, CEO | GGift Class A Common Stock | -35,000 | $0.00 | $0 | 13,068,926 | Dec 31, 2024 |
| Dec 30, 2024 | OKLO Oklo Inc. | DeWitte Jacob Co-Founder, CEO | GGift Class A Common Stockindirect: By Caroline Cochran | -35,000 | $0.00 | $0 | 12,508,085 | Dec 31, 2024 |
| Sep 30, 2021 | EGAN EGAIN Corp | NARANG PROMOD other | AGrant or award Employee Stock Option (right to buy)derivative | +115,000 | $0.00 | $0 | 115,000 | Dec 31, 2024 |
| Sep 30, 2021 | EGAN EGAIN Corp | Darukhanavala Phiroz P director | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Dec 31, 2024 |
| Sep 30, 2021 | EGAN EGAIN Corp | SINHA GUNJAN director | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Dec 31, 2024 |
| Sep 30, 2021 | EGAN EGAIN Corp | SMIT ERIC Chief Financial Officer | AGrant or award Employee Stock Option (right to buy)derivative | +160,000 | $0.00 | $0 | 160,000 | Dec 31, 2024 |
| Sep 30, 2021 | EGAN EGAIN Corp | CHRISTINE RUSSELL director | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Dec 31, 2024 |
| Sep 30, 2021 | EGAN EGAIN Corp | SHOCKLEY BRETT A director | AGrant or award Stock Option (right to buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Dec 31, 2024 |
| Sep 30, 2021 | EGAN EGAIN Corp | ROY ASHUTOSH Chief Executive Officer | AGrant or award Employee Stock Option (right to buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Dec 31, 2024 |
| Dec 30, 2024 | BSY BENTLEY SYSTEMS INC | Shaman David R. Chief Legal Officer | GGift Class B Common Stockindirect: By Grantor Retained Annuity Trusts | -45,763 | $0.00 | $0 | 269,878 | Dec 31, 2024 |
| Dec 29, 2024 | - NORTHERN OIL & GAS, INC. | Allen Chad W CFO | FTax withholding Common Stock | -4,978 | $36.04 | $179k | 76,814 | Dec 31, 2024 |
| Dec 29, 2024 | - NORTHERN OIL & GAS, INC. | Dirlam Adam A. President | FTax withholding Common Stock | -6,637 | $36.04 | $239k | 97,895 | Dec 31, 2024 |
| Dec 27, 2024 | UAN CVR PARTNERS, LP | ICAHN CARL C owner | POpen-market purchase Common Unitsindirect: Please see footnotes | +1,698 | $74.88 | $127k | 171,352 | Dec 31, 2024 |
| Dec 30, 2024 | UAN CVR PARTNERS, LP | ICAHN CARL C owner | POpen-market purchase Common Unitsindirect: Please see footnotes | +2,840 | $74.74 | $212k | 174,192 | Dec 31, 2024 |
| Aug 28, 2017 | CCRN CROSS COUNTRY HEALTHCARE INC | CASH W LARRY director | POpen-market purchase Common Stock | +2,000 | $12.08 | $24k | 195,632 | Dec 31, 2024 |
| Aug 10, 2018 | CCRN CROSS COUNTRY HEALTHCARE INC | CASH W LARRY director | POpen-market purchase Common Stock | +4,000 | $9.29 | $37k | 199,632 | Dec 31, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.